THIS ANNOUNCEMENT AND THE
INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, NEW
ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER
JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION
WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT CONTAINS INSIDE
INFORMATION FOR IMMEDIATE RELEASE.
Inspiration Healthcare Group Plc
("Inspiration Healthcare" or the "Company")
Result of
General Meeting and Total Voting Rights
On 26 June 2024, Inspiration
Healthcare (AIM: IHC), the global medical technology company
pioneering specialist intensive neonatal intensive care medical
devices, announced (the "Launch
Announcement") a conditional placing (the "Placing"), a Director and senior
management Subscription (the "Subscription"), and an associated
retail offer (the "Retail
Offer").
The Company is pleased to announce
that at its General Meeting held earlier today, all the resolutions
set out in the circular dated 28 June 2024 were duly passed (the
"Resolutions").
Further to this, the Company can now
confirm that it will issue, pursuant to the Placing, the
Subscription and the Retail Offer, 21,428,570 New Ordinary Shares
at 14 pence per share, raising approximately £3.0 million in
aggregate. The issue of New Ordinary Shares will be split as
follows:
·
17,321,430 shares pursuant
to the Placing, raising gross proceeds of approximately
£2.4 million;
·
535,712 shares pursuant to the Subscription,
raising gross proceeds of approximately £75,000; and
·
3,571,428 shares pursuant to the Retail Offer,
raising gross proceeds of approximately £0.5 million.
As a result of the passing of the
Resolutions, the Directors and senior management of the Company
participating in the Capital Raising will hold the following
Ordinary Shares in the capital of the Company on
Admission:
Director
|
Existing beneficial
shareholding
|
New Ordinary Shares
subscribed for
|
Shareholding on completion
of the Capital Raising
|
Shareholding as a percentage
of the Enlarged Issued Share Capital
|
Roy
Davis
|
-
|
178,571
|
178,571
|
0.20%
|
Neil
Campbell*
|
4,416,646
|
71,428*
|
4,488,074
|
5.01%
|
Liz
Shanahan
|
35,000
|
142,857
|
177,857
|
0.20%
|
Simon
Motley
|
4,111,628
|
107,142
|
4,218,770
|
4.71%
|
Laura
Edwards
|
-
|
35,714
|
35,714
|
0.04%
|
*To be gifted to his
children
The Company has applied to the
London Stock Exchange for the 21,428,570 New Ordinary Shares to be
admitted to trading on AIM ("Admission"). It is expected that the
Admission will occur at 8:00 a.m. on 23 July 2024.
Following Admission, the Company's
issued share capital will comprise 89,663,372 ordinary shares of 10
pence each and that number may be used by shareholders in the
Company as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change in their interest in, the share capital of the Company under
the FCA's Disclosure Guidance and Transparency Rules. The Company
does not hold any shares in treasury.
Capitalised terms not defined in
this announcement have the meanings given to them in the Launch
Announcement.
Commenting, Roy Davis, Interim Chief
Executive of Inspiration Healthcare, said: "We're very pleased to have
been able to complete this equity raise in challenging market
conditions. The additional funds raised will enable us to reduce
our net debt and will provide us with significant liquidity
headroom. The Directors and Senior Management have participated in
the raise, highlighting both our commitment to and belief in the
Company. We would also like to thank our existing investors for
their continued support. We look forward to a productive second
half as we continue to execute our strategy."
Change of Name of Nominated Adviser
and Broker
The Company's Nominated Adviser and
Broker has changed its name to Panmure Liberum Capital
Limited.
For
more information contact:
|
|
Inspiration Healthcare Group plc
|
Tel: +44 (0)330 175 0000
|
Roy Davis, Executive Chairman and
Interim CEO
|
|
Alan Olby, Chief Financial
Officer
|
|
|
|
|
|
|
|
Panmure Liberum Capital Limited (Nomad and
Broker)
|
Tel: 020
3100 2000
|
Richard Lindley, Will King, Joshua
Borlant
|
|
|
|
|
|
Walbrook PR Ltd
|
Tel: 020
7933 8700 or
inspirationhealthcare@walbrookpr.com
|
Anna Dunphy
Stephanie Cuthbert
Louis Ashe-Jepson
|
Mob: 07876
741 001
Mob: 07796
794 663
Mob: 07747
515 393
|
|
|
|
| |
About Inspiration Healthcare Group
plc
Inspiration Healthcare (AIM: IHC)
designs, manufactures and markets pioneering medical technology.
Based in the UK, the Company specialises in neonatal intensive care
medical devices, which are addressing a critical need to help to
save the lives and improve the outcomes of patients, starting with
the very first breaths of life.
The Company has a broad portfolio of
its own products and complementary distributed products, for use in
neonatal intensive care designed to support even the most premature
babies throughout their hospital stay. Its own branded products
range from highly sophisticated capital equipment such as
ventilators for life support through to single-use
disposables.
The Company sells its products
directly to hospitals and healthcare providers in the UK and
Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy. In the rest of the world
the Company has an established network of distribution partners
around the world giving access to more than 75
countries.
The Company operates in the UK from
its world-class Manufacturing and Technology Centre in Croydon,
South London and in the USA from its facility in Melbourne,
Florida.
Further information on Inspiration
Healthcare can be found at
www.inspirationhealthcaregroup.com
Note:
The information contained within
this Announcement is deemed by the Company to constitute inside
information as stipulated under the Market Abuse Regulation (EU
Regulation No. 596/2014) (as it forms part of United Kingdom
domestic law by virtue of the European Union (Withdrawal) Act 2018)
(the "UK MAR"). Upon
the publication of this Announcement via a Regulatory Information
Service, this inside information is now considered to be in the
public domain. If you have any queries on this, then please contact
Alan Olby, Finance Director of the Company (the person responsible
for arranging the release of this Announcement) on +44 (0)330 175
0000